FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074805250> ?p ?o ?g. }

• W2074805250 endingPage "373" @default.
• W2074805250 startingPage "365" @default.
• W2074805250 abstract "Treatment of glioblastoma with platinum compounds modestly improves progression-free survival and may cause toxic effects which prevent use at higher dose that would otherwise improve the antineoplastic effect. To reduce toxicity, we propose to encapsulate the platinum drug in a liposome. We have also tested three methods of drug administration (intra-venous, intra-arterial and intra-arterial combined with blood brain barrier disruption) to determine which one optimizes the tumor cell uptake, limits the toxicity and delivers the best concomitance effect with radiotherapy. Cisplatin, oxaliplatin, their respective liposomal formulations, Lipoplatin™ and Lipoxal™, and carboplatin were assessed in F98 glioma, orthotopically implanted in Fischer rats. We found that the modest accumulation of drugs in tumor cells after intra-venous injection was significantly improved when the intra-arterial route was used and further increased after the transient opening of the blood brain barrier with mannitol. The liposomal formulations have largely reduced the toxicity and have allowed a better exploitation of the anti-cancer activity of platinum agent. Although the liposomes Lipoplatin™ and Lipoxal™ have shown a similar ability to that of carboplatin, to accumulate in brain tumors, the highest additive effect with radiotherapy was obtained with carboplatin. We conclude that the intra-arterial infusion of carboplatin or Lipoxal™ in concomitance with radiation therapy leads to the best tumor control as measured by an increase of mean survival time in Fischer rats implanted with the F98 glioma with a benefit in survival time of 13.4 and 6.5 days respectively compared to intra-venous." @default.
• W2074805250 created "2016-06-24" @default.
• W2074805250 creator A5011257685 @default.
• W2074805250 creator A5030315115 @default.
• W2074805250 creator A5034651584 @default.
• W2074805250 creator A5045232357 @default.
• W2074805250 creator A5090541293 @default.
• W2074805250 date "2013-09-13" @default.
• W2074805250 modified "2023-10-11" @default.
• W2074805250 title "Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain" @default.
• W2074805250 cites W1551978591 @default.
• W2074805250 cites W161606654 @default.
• W2074805250 cites W1617704023 @default.
• W2074805250 cites W191454705 @default.
• W2074805250 cites W1963665239 @default.
• W2074805250 cites W1968782197 @default.
• W2074805250 cites W1998819691 @default.
• W2074805250 cites W2002516695 @default.
• W2074805250 cites W2019300898 @default.
• W2074805250 cites W2021609364 @default.
• W2074805250 cites W2022679613 @default.
• W2074805250 cites W2025374889 @default.
• W2074805250 cites W2038009041 @default.
• W2074805250 cites W2087287145 @default.
• W2074805250 cites W2090686331 @default.
• W2074805250 cites W2115496571 @default.
• W2074805250 cites W2123605603 @default.
• W2074805250 cites W2129320713 @default.
• W2074805250 cites W2146656308 @default.
• W2074805250 cites W2318537454 @default.
• W2074805250 cites W2323915847 @default.
• W2074805250 cites W2413980494 @default.
• W2074805250 doi "https://doi.org/10.1007/s11060-013-1238-8" @default.
• W2074805250 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3829823" @default.
• W2074805250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24026531" @default.
• W2074805250 hasPublicationYear "2013" @default.
• W2074805250 type Work @default.
• W2074805250 sameAs 2074805250 @default.
• W2074805250 citedByCount "45" @default.
• W2074805250 countsByYear W20748052502014 @default.
• W2074805250 countsByYear W20748052502015 @default.
• W2074805250 countsByYear W20748052502016 @default.
• W2074805250 countsByYear W20748052502017 @default.
• W2074805250 countsByYear W20748052502018 @default.
• W2074805250 countsByYear W20748052502019 @default.
• W2074805250 countsByYear W20748052502020 @default.
• W2074805250 countsByYear W20748052502021 @default.
• W2074805250 countsByYear W20748052502022 @default.
• W2074805250 countsByYear W20748052502023 @default.
• W2074805250 crossrefType "journal-article" @default.
• W2074805250 hasAuthorship W2074805250A5011257685 @default.
• W2074805250 hasAuthorship W2074805250A5030315115 @default.
• W2074805250 hasAuthorship W2074805250A5034651584 @default.
• W2074805250 hasAuthorship W2074805250A5045232357 @default.
• W2074805250 hasAuthorship W2074805250A5090541293 @default.
• W2074805250 hasBestOaLocation W20748052502 @default.
• W2074805250 hasConcept C121608353 @default.
• W2074805250 hasConcept C126322002 @default.
• W2074805250 hasConcept C142724271 @default.
• W2074805250 hasConcept C185154212 @default.
• W2074805250 hasConcept C185592680 @default.
• W2074805250 hasConcept C2776694085 @default.
• W2074805250 hasConcept C2778227246 @default.
• W2074805250 hasConcept C2778239845 @default.
• W2074805250 hasConcept C2779130545 @default.
• W2074805250 hasConcept C2779384505 @default.
• W2074805250 hasConcept C2780035454 @default.
• W2074805250 hasConcept C2780962732 @default.
• W2074805250 hasConcept C2781451048 @default.
• W2074805250 hasConcept C29730261 @default.
• W2074805250 hasConcept C502942594 @default.
• W2074805250 hasConcept C509974204 @default.
• W2074805250 hasConcept C526805850 @default.
• W2074805250 hasConcept C55493867 @default.
• W2074805250 hasConcept C71924100 @default.
• W2074805250 hasConcept C98274493 @default.
• W2074805250 hasConceptScore W2074805250C121608353 @default.
• W2074805250 hasConceptScore W2074805250C126322002 @default.
• W2074805250 hasConceptScore W2074805250C142724271 @default.
• W2074805250 hasConceptScore W2074805250C185154212 @default.
• W2074805250 hasConceptScore W2074805250C185592680 @default.
• W2074805250 hasConceptScore W2074805250C2776694085 @default.
• W2074805250 hasConceptScore W2074805250C2778227246 @default.
• W2074805250 hasConceptScore W2074805250C2778239845 @default.
• W2074805250 hasConceptScore W2074805250C2779130545 @default.
• W2074805250 hasConceptScore W2074805250C2779384505 @default.
• W2074805250 hasConceptScore W2074805250C2780035454 @default.
• W2074805250 hasConceptScore W2074805250C2780962732 @default.
• W2074805250 hasConceptScore W2074805250C2781451048 @default.
• W2074805250 hasConceptScore W2074805250C29730261 @default.
• W2074805250 hasConceptScore W2074805250C502942594 @default.
• W2074805250 hasConceptScore W2074805250C509974204 @default.
• W2074805250 hasConceptScore W2074805250C526805850 @default.
• W2074805250 hasConceptScore W2074805250C55493867 @default.
• W2074805250 hasConceptScore W2074805250C71924100 @default.
• W2074805250 hasConceptScore W2074805250C98274493 @default.
• W2074805250 hasIssue "3" @default.
• W2074805250 hasLocation W20748052501 @default.

• next